175 related articles for article (PubMed ID: 36262330)
1. Identification and functional characterization of
Huang M; Yang L; Zhou L; Sun C; Zhao W; Peng J; Jiao Z; Tian C; Guo G
Front Microbiol; 2022; 13():990318. PubMed ID: 36262330
[TBL] [Abstract][Full Text] [Related]
2.
Lv QZ; Qin YL; Yan L; Wang L; Zhang C; Jiang YY
Front Microbiol; 2018; 9():218. PubMed ID: 29515531
[TBL] [Abstract][Full Text] [Related]
3. The putative ABC transporter encoded by the orf19.4531 plays a role in the sensitivity of Candida albicans cells to azole antifungal drugs.
Jiang L; Xu D; Chen Z; Cao Y; Gao P; Jiang Y
FEMS Yeast Res; 2016 May; 16(3):. PubMed ID: 26975389
[TBL] [Abstract][Full Text] [Related]
4.
Sun Y; Tan L; Yao Z; Gao L; Yang J; Zeng T
Microbiol Spectr; 2022 Feb; 10(1):e0200721. PubMed ID: 35019705
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of ORF19.1725, a novel gene contributing to the white cell pheromone response and virulence-associated functions in Candida albicans.
Deng FS; Lin CH
Virulence; 2018 Dec; 9(1):866-878. PubMed ID: 29726301
[TBL] [Abstract][Full Text] [Related]
6. The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation.
Liu Y; Ren H; Wang D; Zhang M; Sun S; Zhao Y
Biomed Pharmacother; 2020 Oct; 130():110580. PubMed ID: 32745913
[TBL] [Abstract][Full Text] [Related]
7. Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence.
Zhang M; Yan H; Lu M; Wang D; Sun S
Int J Antimicrob Agents; 2020 Jan; 55(1):105804. PubMed ID: 31605727
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Effects and Mechanisms of Combined Treatment With Harmine Hydrochloride and Azoles for Resistant
Li X; Wu X; Gao Y; Hao L
Front Microbiol; 2019; 10():2295. PubMed ID: 31749766
[TBL] [Abstract][Full Text] [Related]
9. Loss of Upc2p-Inducible
Luna-Tapia A; Willems HME; Parker JE; Tournu H; Barker KS; Nishimoto AT; Rogers PD; Kelly SL; Peters BM; Palmer GE
mBio; 2018 May; 9(3):. PubMed ID: 29789366
[TBL] [Abstract][Full Text] [Related]
10. Verapamil inhibits efflux pumps in
Vega-Chacón Y; de Albuquerque MC; Pavarina AC; Goldman GH; Mima EGO
Virulence; 2021 Dec; 12(1):231-243. PubMed ID: 33410730
[TBL] [Abstract][Full Text] [Related]
11. The impact of ORF19.36.1 in the pathobiology of Candida albicans.
Arita GS; Ma Q; Leaves I; Pradhan A; Hickey E; Dambuza I; Bebes A; Vincenzi Conrado PC; Barros Galinari C; Vicente Seixas FA; Kioshima ÉS; de Souza Bonfim-Mendonça P; Svidzinski TIE; Brown AJP
Microb Pathog; 2023 Dec; 185():106437. PubMed ID: 37913825
[TBL] [Abstract][Full Text] [Related]
12. Linezolid in Combination With Azoles Induced Synergistic Effects Against
Lu M; Yang X; Yu C; Gong Y; Yuan L; Hao L; Sun S
Front Microbiol; 2018; 9():3142. PubMed ID: 30766527
[TBL] [Abstract][Full Text] [Related]
13. Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans.
Calabrese EC; Castellano S; Santoriello M; Sgherri C; Quartacci MF; Calucci L; Warrilow AG; Lamb DC; Kelly SL; Milite C; Granata I; Sbardella G; Stefancich G; Maresca B; Porta A
J Antimicrob Chemother; 2013 May; 68(5):1111-9. PubMed ID: 23292344
[TBL] [Abstract][Full Text] [Related]
14. Antifungal activity and potential mechanism of Asiatic acid alone and in combination with fluconazole against Candida albicans.
Wang Y; Lu C; Zhao X; Wang D; Liu Y; Sun S
Biomed Pharmacother; 2021 Jul; 139():111568. PubMed ID: 33845374
[TBL] [Abstract][Full Text] [Related]
15. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
[TBL] [Abstract][Full Text] [Related]
16. Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis.
Morio F; Lombardi L; Binder U; Loge C; Robert E; Graessle D; Bodin M; Lass-Flörl C; Butler G; Le Pape P
J Antimicrob Chemother; 2019 Aug; 74(8):2230-2238. PubMed ID: 31106355
[TBL] [Abstract][Full Text] [Related]
17. Species-Specific Differences in C-5 Sterol Desaturase Function Influence the Outcome of Azole Antifungal Exposure.
Luna-Tapia A; Parker JE; Kelly SL; Palmer GE
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0104421. PubMed ID: 34516249
[TBL] [Abstract][Full Text] [Related]
18. In vivo activity of fluconazole/tetracycline combinations in Galleria mellonella with resistant Candida albicans infection.
Gu W; Yu Q; Yu C; Sun S
J Glob Antimicrob Resist; 2018 Jun; 13():74-80. PubMed ID: 29191612
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018).
Arastehfar A; Yazdanpanah S; Bakhtiari M; Fang W; Pan W; Mahmoudi S; Pakshir K; Daneshnia F; Boekhout T; Ilkit M; Perlin DS; Zomorodian K; Zand F
Med Mycol; 2021 May; 59(5):422-430. PubMed ID: 32692816
[TBL] [Abstract][Full Text] [Related]
20. Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic
Revie NM; Robbins N; Whitesell L; Frost JR; Appavoo SD; Yudin AK; Cowen LE
mSphere; 2020 Apr; 5(2):. PubMed ID: 32269162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
